Published in Can Med Assoc J on August 23, 1969
Hydronephrosis due to pelviureteric junction narrowing: Utility of urinary enzymes to predict the need for surgical management and follow-up. J Indian Assoc Pediatr Surg (2012) 1.05
Renal lysozyme levels in animals developing Proteus mirabilis-induced pyelonephritis. Appl Microbiol (1971) 0.87
Acid base and electrolyte equilibrium of arterial blood and cerebro-spinal fluid in respiratory insufficiency. Respiration (1969) 11.02
Serum and urinary lysozyme (muramidase) in monocytic and monomyelocytic leukemia. J Exp Med (1966) 9.20
The use of the catalase test to detect significant bacteriuria. Am J Med Sci (1966) 2.66
THE RELIABILITY OF SCREENING TESTS FOR BACTERIURIA IN PREGNANCY. Lancet (1964) 2.59
Urinary lactic dehydrogenase activity. I. Screening method for detection of cancer of kidneys and bladder. JAMA (1962) 2.30
Urinary lysozyme, ribonuclease, and low-molecular-weight protein in renal disease. Lancet (1968) 1.87
A STUDY OF URINARY AND SERUM LYSOZYME IN PATIENTS WITH RENAL DISEASE. N Engl J Med (1964) 1.65
Urinary lactic dehydrogenase in renal disease. Lancet (1959) 1.43
Proteinuria in chronic cadmium poisoning. 3. Electrophoretic and immunoelectrophoretic studies on urinary proteins from cadmium workers, with special reference to the excretion of low molecular weight proteins. Arch Environ Health (1966) 1.31
URINARY ALKALINE PHOSPHATASE ACTIVITY. I. ELEVATED URINARY LDH AND ALKALINE PHOSPHATASE ACTIVITIES FOR THE DIAGNOSIS OF RENAL ADENOCARCINOMAS. JAMA (1963) 1.29
Urinary muramidase and renal disease. Correlation with renal histology and implication for the mechanism of enzymuria. N Engl J Med (1968) 1.20
URINARY LACTIC DEHYDROGENASE ACTIVITY. IV. SCREENING TEST FOR DETECTION OF RENAL DISEASE DISSOCIATED AND IN ASSOCIATION WITH ARTERIAL HYPERTENSION. JAMA (1964) 1.20
Lysozymuria induced in rats by nephrotoxic agents. Proc Soc Exp Biol Med (1966) 1.09
Urine and serum lysozyme measurement in renal homotransplantation. Proc Soc Exp Biol Med (1965) 1.08
Urinary excretion of acid phosphatase. Br Med J (1954) 1.07
SERUM AND URINARY LACTIC DEHYDROGENASE IN PATIENTS WITH RENAL HOMOTRANSPLANTS. Surgery (1964) 1.04
Cadaver kidney transplants. Transplantation (1967) 1.02
Urinary beta-glucuronidase activity in cancer of the bladder and other diseases. Br J Cancer (1960) 0.93
THE ORIGIN OF URINARY BETA-GLUCURONIDASE. Br J Cancer (1965) 0.91
Automated assay of lactate dehydrogenase in urine. Anal Biochem (1965) 0.91
A STUDY OF LACTIC DEHYDROGENASE IN URINE AND SERUM OF PATIENTS WITH URINARY TRACT DISEASE. J Urol (1963) 0.90
On the origin of lactic dehydrogenase isoenzymes in urine. Helv Med Acta (1966) 0.89
Studies on urinary lipase. III. On the diagnostic value of urinary lipase. AMA Arch Intern Med (1957) 0.88
Urinary lactic dehydrogenase: a report based on 250 hospitalized patients. J Urol (1966) 0.84
PATTERNS OF URINARY EXCRETION OF ALKALINE PHOSPHATASE IN ACUTE RENAL FAILURE. Clin Chim Acta (1965) 0.84
Alkaline phosphatase in bile and urine. Excretion in patients with hepatobiliary disease. Arch Intern Med (1967) 0.83
Evaluation of the urinary catalase test in hypertensive vascular disease. J Lab Clin Med (1962) 0.83
Urinary enzymes in benign and malignant urinary tract disorders: alkaline phosphatase and lactic acid dehydrogenase. Br J Urol (1967) 0.82
Some properties of lactate dehydrogenase found in human urine. Biochem J (1967) 0.82
URINARY ALKALINE PHOSPHATASE AND LDH ACTIVITIES IN THE DIFFERENTIAL DIAGNOSIS OF RENAL DISEASE. Ann Intern Med (1965) 0.82
[Renal enzyme excretion in proteinuria]. Klin Wochenschr (1958) 0.82
Urinary lactic dehydrogenase, alkaline phosphatase and lysozyme studies in renal disease. Can Med Assoc J (1966) 0.81
Urine beta glucuronidase activity in urinary tract disease. J Urol (1967) 0.81
Lactic dehydrogenase in renal disease. Urinary concentrations and relative clearances. Lancet (1961) 0.80
Urine and serum lysozyme alterations in a case of acute renal failure. J Urol (1966) 0.80
[Enzyme activity of urine in nephropathies]. Rev Fr Etud Clin Biol (1960) 0.80
Serum and urinary enzyme activity after renal infarction. Can Med Assoc J (1965) 0.80
LACTIC DEHYDROGENASE ISOZYMES IN URINE FROM PATIENTS WITH MALIGNANCIES OF THE URINARY BLADDER. J Lab Clin Med (1965) 0.80
The activity of beta-glucuronidase in cases of bladder neoplasms. J Urol (1965) 0.79
Peptide inhibitors of lactic dehydrogenase (LDH). II. Isolation and characterization of peptides I and II. Biochemistry (1966) 0.79
The clinical significance of increased activity of urinary lactic dehydrogenase. J Urol (1966) 0.78
[Clinical and experimental studies on the problem of enzyme elimination from blood serum]. Klin Wochenschr (1958) 0.77
Urinary lactic acid dehydrogenase activity in the diagnosis of urologic neoplasms. J Urol (1966) 0.76
Purification and characterisation of beta-glucuronidase from normal human urine. Scand J Clin Lab Invest (1965) 0.76
[Dynamics of urinary catalase activity in kidney diseases]. Pol Arch Med Wewn (1965) 0.76
Lactic dehydrogenase activity in genitourinary and other diseases. Invest Urol (1966) 0.76
Hypertension, pyelonephritis and renal failure. Clinical interrelations. Am J Cardiol (1966) 0.76
[Clinical significance of the determination of urinary lactate dehydrogenase]. Minerva Med (1966) 0.76
[Characterization of the isoenzymes of urinary lactate dehydrogenase]. Minerva Med (1966) 0.76
Heat fractionation of urine lactic acid dehydrogenase and combined cytopathologic evaluation in the diagnosis of cancer of the urinary tract. J Urol (1966) 0.76
[URINARY CATALASE IN RENAL DISEASES]. Presse Med (1965) 0.76
[Significance of urinary enzyme determination]. Curr Probl Clin Biochem (1968) 0.76
ON THE NATURE OF THE INHIBITOR OF URINARY ALKALINE PHOSPHATASE. Clin Chem (1965) 0.76
[Urinary and plasma beta-glucuronidase and their relation to vesical neoplasia]. Urol Int (1965) 0.76
Lactic dehydrogenase activity in human semen. Proc Soc Exp Biol Med (1958) 0.76
A competitive alkaline phosphatase inhibitor from extracts of normal male urines. Enzymologia (1958) 0.76
RENAL ORIGIN OF URINARY ACID PHOSPHATASE IN NORMAL AND IN PATIENTS WITH CANCER OF THE PROSTATE. Invest Urol (1965) 0.76
Lactate dehydrogenase in urinary tract disease. Br J Urol (1966) 0.76
[LACTATE DEHYDROGENASE ACTIVITY IN THE URINE IN UROLOGICAL AND GENERAL DISEASES]. Urol Int (1964) 0.76
Urinary lysozyme; lysozymuria in healthy children and in children with miscellaneous diseases; a sex difference. J Pediatr (1950) 0.76
Significance of total urinary lactic dehydrogenase activity in urinary tract diseases. J Urol (1966) 0.76
CONFIRMATION OF THE SOURCE OF ELEVATED URINARY LACTIC DEHYDROGENASE IN PATIENTS WITH RENAL TUMOR. J Urol (1964) 0.76
[Urinary lactic dehydrogenase activity in patients with diseases of the kidney and urinary tract]. Nord Med (1966) 0.76
Determination of lactic dehydrogenase in the urine as an aid to the diagnosis of cancer of the kidney. Acta Chir Scand (1966) 0.76
[Activity of alkaline phosphatase in the urine]. Klin Wochenschr (1966) 0.76
Beta-glucuronidase excretion in hypertensive patients. Am J Med Sci (1967) 0.76
COMBINED LACTIC ACID DEHYDROGENASE AND CYTOLOGIC EXAMINATIONS OF URINE IN THE DIAGNOSIS OF CANCER OF THE URINARY TRACT. Acta Cytol (1964) 0.76
ALKALINE PHOSPHATASE IN URINE. Scand J Clin Lab Invest (1964) 0.76
DIAGNOSTIC SIGNIFICANCE OF URINARY LACTIC ACID DEHYDROGENASE. J Urol (1964) 0.76
Studies of human kidney and urine beta-glucuronidase: II. In vitro and in vivo factors influencing measurement. Enzymol Biol Clin (Basel) (1967) 0.76
[CATALASE AND NITRITE TESTS IN THE DETECTION OF URINARY INFECTIONS]. Nord Med (1963) 0.76
[Urinary elimination of various enzymes in subjects with intact kidneys and in kidney disease patients: correlation with the proteinuria entity]. Riforma Med (1962) 0.76
[Serum content and urinary elimination of leucine-aminopeptidase in women with carcinoma of the uterine cervix]. Ann Ostet Ginecol (1962) 0.76
[Urinary elimination of lactate dehydrogenase in the course of gravid nephropathy]. Ann Ostet Ginecol Med Perinat (1965) 0.75
[Lactate dehydrogenase activity of the urine in bladder tumors]. Urol Int (1965) 0.75
ACID PHOSPHATASE ACTIVITY IN URETERAL URINE: A TEST FOR UNILATERAL RENAL DISEASE. JAMA (1965) 0.75
Prediction of creatinine clearance from serum creatinine. Nephron (1976) 64.02
The diagnosis and prognosis of autosomal dominant polycystic kidney disease. N Engl J Med (1990) 2.26
Age at clinical onset and at ultrasonographic detection of adult polycystic kidney disease: data for genetic counselling. Am J Med Genet (1984) 2.10
Syndrome associated with the abuse of analgesics. Ann Intern Med (1968) 1.82
Predicting glomerular function from adjusted serum creatinine. Nephron (1992) 1.64
Drinking water hardness and urolithiasis. Ann Intern Med (1978) 1.45
Prognosis of adult onset polycystic kidney disease re-evaluated. Kidney Int (1984) 1.33
Association between hydrocarbon exposure and glomerulonephritis. An appraisal of the evidence. Nephron (1983) 1.24
Clinimetrics in nephrology. Nephron (1986) 1.18
Cadaver kidney transplants. Transplantation (1967) 1.02
Analgesic nephropathy. A clinicopathologic study using electron microscopy. Am J Med (1971) 1.02
Improvements in drug prescription labels for patients with limited education or vision. Can Med Assoc J (1982) 1.01
Analgesic habits of 500 veterans: incidence and complications of abuse. Can Med Assoc J (1968) 1.01
A randomized controlled trial of a brief psychoeducational support group for partners of early stage breast cancer patients. Psychooncology (2000) 0.99
Cerebral and pontine myelinolysis. Two cases with fluid and electrolyte imbalance and hypotension. J Neurol Sci (1973) 0.98
Hypernatremia, azotemia, and dehydration ue to high-protein tube feeding. Ann Intern Med (1968) 0.95
Glomerular injury in patients with neoplasia. Annu Rev Med (1976) 0.93
Hydrolysis of digoxin by acid. J Pharm Pharmacol (1977) 0.91
Left ventricular hypertrophy in end-stage renal disease. Nephron (1988) 0.90
Clinical features and severity of nonspecific symptoms in dialysis patients. Nephron (1988) 0.88
Kidney transplantation and long-term dialysis. Am Heart J (1970) 0.88
Development of a health questionnaire specific for end-stage renal disease. Nephron (1989) 0.88
Missense mutation in the adenine phosphoribosyltransferase gene causing 2,8-dihydroxyadenine urolithiasis. Hum Mol Genet (1994) 0.87
Analgesic nephropathy, 1972-76. Can Med Assoc J (1977) 0.87
Effect of some drugs on clinical laboratory values as determined by the Technicon SMA 12-60. Clin Chem (1972) 0.86
Multiple daily fractionated radiation therapy and misonidazole in the management of malignant astrocytoma. A preliminary report. Cancer (1985) 0.86
Hepatitis with Australia antigenemia following renal transplantation. Can Med Assoc J (1973) 0.86
Misonidazole combined with hyperfractionation in the management of malignant glioma. Int J Radiat Oncol Biol Phys (1984) 0.86
Renal biopsy: current views and controversies. Nephron (1983) 0.84
Urolithiasis--a study of drinking water hardness and genetic factors. J Chronic Dis (1980) 0.84
Analgesic nephropathy in Canada: clinical syndrome, management, and outcome. Kidney Int (1978) 0.84
Persisting renal insufficiency after methoxyflurane anesthesia. Report of two cases and review of literature. Am J Med (1974) 0.83
The plasma phenolsulfonphthalein index (PSPI) of renal function: I. Theoretical considerations and investigative studies. Can Med Assoc J (1966) 0.83
Letter: Creatinine clearance and age. Lancet (1975) 0.83
Significance of a negative cross match in recipients with a wide spectrum of lymphocytotoxic antibodies. Transplantation (1971) 0.83
Biotransformation and elimination of digoxin with normal and minimal renal function. Clin Pharmacol Ther (1979) 0.83
Urinary enzymes in benign and malignant urinary tract disorders: alkaline phosphatase and lactic acid dehydrogenase. Br J Urol (1967) 0.82
Hyperchloremic acidosis in early diagnosis of renal allograft rejection. Ann Intern Med (1969) 0.82
Chronic pyelonephritis: relative incidence in transplant recipients. N Engl J Med (1966) 0.82
Comparison of infrared and wet chemical analysis of urinary tract calculi. Clin Chim Acta (1980) 0.81
Plasma digitalis-like factor(s) increase with salt loading. N Engl J Med (1983) 0.81
Human adenine phosphoribosyltransferase: characterization from subjects with a deficiency of enzyme activity. Biochem Genet (1983) 0.81
Serum enzymes in patients with carcinoma of lung: lactic-acid dehydrogenase, phosphohexose isomerase, alkaline phosphatase and glutamic oxaloacetic transaminase. Can Med Assoc J (1967) 0.80
Evidence for the nephrotoxicity of analgesics. Can Med Assoc J (1972) 0.80
Studies of digoxin dosage, kinetics and serum concentrations in renal failure and review of the literature. Nephron (1976) 0.80
Development of lymphocytotoxic antibodies in hemodialysis patients. Vox Sang (1972) 0.80
Serum and urinary enzyme activity after renal infarction. Can Med Assoc J (1965) 0.80
Preservation of the dog kidney. J Surg Res (1968) 0.79
Symptoms in end-stage renal disease: dialysis v transplantation. Transplant Proc (1987) 0.79
Superfractionation radiation therapy in the treatment of malignant astrocytoma. Cancer (1983) 0.79
Can tamoxifen prevent breast cancer? CMAJ (1993) 0.79
Kidney transplants: computer display of clinical and laboratory parameters. The first 100 days. Can Med Assoc J (1969) 0.79
Fractionation of tritiated digoxin and dihydrodigoxin with DEAE-sephadex LH-20. J Chromatogr (1976) 0.79
Fluid and electrolyte complications of peritoneal dialysis. Choice of dialysis solutions. Ann Intern Med (1971) 0.79
Pediatric urolithiasis in the 1970s. J Urol (1980) 0.79
First morning urine pH in the diagnosis of renal tubular acidosis with nephrolithiasis. Clin Nephrol (1994) 0.78
Declining incidence of analgesic nephropathy in Canada. Can Med Assoc J (1982) 0.78
The oxalate:phosphate ratio in urinary tract calculi by infrared revised analysis. Clin Chim Acta (1987) 0.78
Low-output left ventricular failure in end-stage renal disease. Am J Nephrol (1987) 0.78
Serum ceruloplasmin in hepatobiliary and other disorders: significance of abnormal values. Gastroenterology (1966) 0.78
Tamoxifen and conjugated estrogens (Premarin) followed by sequenced methotrexate and 5-FU in refractory advanced breast cancer. Cancer Treat Rep (1984) 0.77
Comparative value of lymphocyturia, serum, and urinary enzymes in the diagnosis of renal homograft rejection. Surg Forum (1965) 0.77
Dehydroepiandrosterone sulfate as a digitalis like factor in plasma of healthy human adults. Res Commun Chem Pathol Pharmacol (1985) 0.77
Plasma conjugated androgens in a dialysis-dependent male as immunoreactive digitalis-like factors. Clin Nephrol (1990) 0.77
Solitary intrarenal cyst: correctable cause of hypertension. Urology (1975) 0.77
Letter: The clinical course of patients with analgesic nephropathy. Can Med Assoc J (1975) 0.77
Erythromycin-cyclosporine interaction in renal transplant recipients. Transplantation (1987) 0.77
Methemoglobin formation in analgesic nephropathy. Clin Pharmacol Ther (1974) 0.76
Congestive heart failure in dialysis patients. Arch Intern Med (1988) 0.76
Higher values for digitalis-like factors with TDx Digoxin II. Clin Chem (1986) 0.76
Radiation nephritis following combined abdominal radiation and chemotherapy (bleomycin-vinblastine). Cancer (1978) 0.75
The plasma phenolsulfonphthalein index (PSPI) of renal function. II. Correlation with other parameters of renal function and indications for use. Can Med Assoc J (1966) 0.75
Triamterene urolithiasis. Can Med Assoc J (1981) 0.75
Nephrolithiasis in rural practice. Can Med Assoc J (1980) 0.75
Toxic nephropathy after low-dose methoxyflurane anesthesia: drug interaction with secobarbital? Can Med Assoc J (1976) 0.75
Drug metabolites and immunoassays. Clin Chem (1994) 0.75
Adrenocortical hyperfunction associated with bronchogenic carcinoma: report of five cases. Can Med Assoc J (1965) 0.75
Prognosis of common cancers. Can Fam Physician (1990) 0.75
Facing reality. CMAJ (1998) 0.75
Plasma endogenous digitalis-like factors in healthy individuals and in dialysis-dependent and kidney transplant patients. Clin Nephrol (1987) 0.75
Trace elements and hemodialysis. Nephron (1991) 0.75
Would decreased aluminum ingestion reduce the incidence of Alzheimer's disease? CMAJ (1992) 0.75
Peritoneal dialysis solutions. Can Med Assoc J (1973) 0.75
Loading dose of digoxin in renal failure. Br J Clin Pharmacol (1980) 0.75
Occurrence of two cases of cryptococcosis within 3 months on the same general medical ward. Can Med Assoc J (1976) 0.75
Systemic adjuvant therapy for node-negative breast cancer. CMAJ (1989) 0.75
When to use advance treatment directives. CMAJ (1992) 0.75
Combined liquid chromatography/radioimmunoassay with improved specificity for serum digoxin. Clin Chem (1985) 0.75
Prediction of haptoglobin and alpha-2-macroglobulin concentrations for electrophoretic patterns of serum alpha-2-globulin. Clin Chem (1970) 0.75
The place of phenosulfonphthalein (PSP) in the measurement of renal function. Am Heart J (1968) 0.75
Evaluation of renal function without collection of urine. Ann Intern Med (1968) 0.75
Successful skin graft on renal allograft: report of a case. Can J Surg (1971) 0.75
The sixty-minute plasma phenolsulfonphthalein concentration as a test of renal function. Am J Clin Pathol (1969) 0.75
Characteristics of erythropoiesis following human renal homotransplantation. Transplant Proc (1971) 0.75
Methemoglobin formation in patients with renal disease associated with abuse of analgesics containing phenacetin. J Lab Clin Med (1971) 0.75
A unique instance of canine renal homotransplantation with remission of rejection crisis and prolonged survival. Transplantation (1966) 0.75
The effect of acetylsalicylic acid, caffeine, and codeine on the excretion of phenacetin metabolites. Can J Physiol Pharmacol (1972) 0.75
Prediction of immunoglobulins from patterns of cellulose acetate electrophoresis. Clin Chem (1969) 0.75
The plasma phenolsulfonphthalein index (pspi) of renal function. 3. Correlation with urinary PSP excretion in assessment of urological disorders. J Urol (1967) 0.75
Phenolsulfonphthalein (PSP) in assessment of renal function. JAMA (1967) 0.75